CF102 is a synthetic highly-selective agonist of the A3 adenosine receptor (A3AR), a Gi protein associated cell surface receptor, which is highly expressed on the surface of cancerous and inflammatory cells. Binding of CF102 to its target on cells, leads to apoptosis.
Market Data 
Markets 
AI
